ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2630

Rheumatoid Arthritis Patients with Carotid Plaque: 10-Year Follow-up

Raymundo Vera-Pineda1, Alberto Cardenas-de La Garza2, Dionicio A. Galarza-Delgado2, Jose Ramon Azpiri-Lopez3, Iris J. Colunga-Pedraza2, Jorge Munoz De Hoyos2, Griselda Serna-Peña4, Brenda B Tovar-Jasso2, Mario Alberto Garza-Elizondo2 and Gerardo Ornelas5, 1Cardiology., Hospital Universitario, UANL., Monterrey, Mexico, 2Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, 3Cardiology, Hospital Universitario, UANL., Monterrey, Mexico, 4Internal Medicine, Hospital Universitario, UANL., Monterrey, Mexico, 5Radiology, Hospital Universitario, UANL., Monterrey, Mexico

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Atherosclerosis, Cardiovascular disease and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

The main cause of mortality in patients with rheumatoid
arthritis (RA) is atherosclerotic cardiovascular disease (ASCVD). RA patients
have a 10-year decrease in life expectancy when compared to healthy controls. Reports
of ASCVD outcomes in Hispanic RA patients is scarce. The objective of the
present study is to determine the mortality of a Hispanic RA cohort followed
for a 10-year period, and its relation to the presence of carotid plaque (CP)
after initial carotid ultrasound evaluation. 

Methods:

An observational, longitudinal, descriptive study was
designed based on a cohort that included 124 Hispanic patients with RA who
fulfilled the ACR 1987 classification criteria. A telephonic questionnaire was
applied to the subjects or family members to determine ASCVD-related mortality
and new onset of comorbidities (hypertension, diabetes, dyslipidemia, acute
myocardial infarction, stroke, arrhythmias, heart failure, angina, and chronic
kidney disease). A descriptive analysis of current and past comorbidities was
carried out. Survival analysis was performed with Kaplan-Meier curves. Log-Rank
test was used to compare between patients with and without carotid plaque (CP),
considering statistically significant a difference in mortality if a value of
p<.05 was obtained.

Results:

The original cohort included 124 subjects of which 52 were
lost to follow-up. A total of 72 patients were included in the analysis (Table
1). CP was present in 44 (61.11%) of the patients. Of the 72 patients, 11
(15.3%) had died: 7 (9.7%) of them due to ASCVD (4 myocardial infarctions, 2
strokes, 1 heart failure), 2 of non-cardiovascular
causes and 2 in traffic accidents. Diabetes mellitus type 2 was diagnosed in 6
(10.6%) of the remaining patients, hypertension in 24 (39.34%) and dyslipidemia
in 12 (25%). Only 1 patient had a non-lethal myocardial infarction. In the CP
group, 8 (18%) had died against 3 (10.7%) of the patients without CP (Figure
1). The majority of ASCVD-related deaths occurred in patients with CP, although
there was no difference in mortality (p=.373).

Conclusion:

ASCVD was the most frequent cause of death in this cohort.
In a 10-year period, there was no difference in mortality in RA in relation to
the presence of CP. Prospective studies with a greater sample are necessary to
corroborate this finding.


Disclosure: R. Vera-Pineda, None; A. Cardenas-de La Garza, None; D. A. Galarza-Delgado, None; J. R. Azpiri-Lopez, None; I. J. Colunga-Pedraza, None; J. Munoz De Hoyos, None; G. Serna-Peña, None; B. B. Tovar-Jasso, None; M. A. Garza-Elizondo, None; G. Ornelas, None.

To cite this abstract in AMA style:

Vera-Pineda R, Cardenas-de La Garza A, Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Munoz De Hoyos J, Serna-Peña G, Tovar-Jasso BB, Garza-Elizondo MA, Ornelas G. Rheumatoid Arthritis Patients with Carotid Plaque: 10-Year Follow-up [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/rheumatoid-arthritis-patients-with-carotid-plaque-10-year-follow-up/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-patients-with-carotid-plaque-10-year-follow-up/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology